Source link : https://newshealth.biz/health-news/ivonescimab-delays-lung-cancer-progression-in-egfr-mutated-disease/
(MedPage Today) — Adding ivonescimab to chemotherapy prolonged progression-free survival (PFS) in previously treated advanced EGFR-mutant non-small cell lung cancer (NSCLC), but failed to significantly improve overall survival (OS), the phase… Source link : https://www.medpagetoday.com/meetingcoverage/iaslc/117380 Author : Publish date : 2025-09-09 19:22:00 Copyright for syndicated content belongs to the linked Source.
The post Ivonescimab Delays Lung Cancer Progression in EGFR-Mutated Disease first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-09 19:22:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8